TG1
Angelic Poster
Udarnik,
It's worth your time to dig into Pharmacyclics. I'd really welcome your thoughts about it.
Yeah, inventors almost always get screwed. Admittedly, like all startups, the company seemed to have some cray cray in its DNA. Duggan leveraged his investment by running off the founder back in 2008.
But it's the two people who seem closest to Duggan (the COO and the investor information VP) who have my attention. COO Maky Zanganey has been with Duggan for ten years or longer. She's a French-Persian with a D.D.S. whose "interesting" background and psychology are described at http://www.fiercebiotech.com/special-reports/maky-zanganeh-top-women-biotech-2013. At that link, Duggan describes his protege as a "... make it go right and do what needs to be done" entrepreneur."
By now, you should be able to translate that Scientologese into "get the stat up by Thursday at two o'clock, no matter what you have to do to make it happen!"
And the investor relations chief (Ramses Erdtmann) is a German broker-dealer OT8, which has to be the trifecta of skills in this sector of the galaxy for making it go right. (See above.)
If/when the CFO (Manmeet Soni) and/or key medicos/trials people are replaced, my spidey senses will be on fire.
TG1
It's worth your time to dig into Pharmacyclics. I'd really welcome your thoughts about it.
Yeah, inventors almost always get screwed. Admittedly, like all startups, the company seemed to have some cray cray in its DNA. Duggan leveraged his investment by running off the founder back in 2008.
But it's the two people who seem closest to Duggan (the COO and the investor information VP) who have my attention. COO Maky Zanganey has been with Duggan for ten years or longer. She's a French-Persian with a D.D.S. whose "interesting" background and psychology are described at http://www.fiercebiotech.com/special-reports/maky-zanganeh-top-women-biotech-2013. At that link, Duggan describes his protege as a "... make it go right and do what needs to be done" entrepreneur."
By now, you should be able to translate that Scientologese into "get the stat up by Thursday at two o'clock, no matter what you have to do to make it happen!"
And the investor relations chief (Ramses Erdtmann) is a German broker-dealer OT8, which has to be the trifecta of skills in this sector of the galaxy for making it go right. (See above.)
If/when the CFO (Manmeet Soni) and/or key medicos/trials people are replaced, my spidey senses will be on fire.
TG1